Literature DB >> 20975555

Diet and cognition in chronic liver disease.

Toufic Kachaamy1, Jasmohan S Bajaj.   

Abstract

PURPOSE OF REVIEW: The spectrum of neurocognitive impairment in cirrhosis spans a continuum of minimal hepatic encephalopathy (MHE) to overt hepatic encephalopathy (OHE), the pathophysiology of which remains incompletely understood. The current available evidence, however, suggests that nutrition plays an important role in its development and points to the fact that malnutrition increases the morbidity and mortality of patients with cirrhosis. This review incorporates recent findings published in the last 2 years within the evolution of evidence regarding the role dietary manipulation can play in the comprehensive management of patients with cirrhosis and cognitive dysfunction. RECENT
FINDINGS: In patients with cirrhosis it is important to prevent starvation physiology which occurs after few hours of caloric deprivation as compared to 3 days in noncirrhotics. This can be accomplished by making sure that cirrhotic patients have daily breakfast and a late evening snack. In addition, probiotics and symbiotics are well tolerated and improve cognitive function in patients with MHE.
SUMMARY: The long-time held belief that protein restriction is needed to improve encephalopathy has no scientific basis but remains widely practiced. Branched-chain amino acids supplement may be helpful in patients who continue to suffer from OHE despite treatment of precipitating events and pharmacologic treatment with lactulose and rifaximin. Preventing starvation physiology and supplementing the diet with prebiotics and symbiotics are helpful in patients with MHE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20975555     DOI: 10.1097/MOG.0b013e3283409c25

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  11 in total

1.  An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.

Authors:  Takumi Kawaguchi; Takuro Suetsugu; Shyou Ogata; Minami Imanaga; Kumiko Ishii; Nao Esaki; Masako Sugimoto; Jyuri Otsuyama; Ayu Nagamatsu; Eitaro Taniguchi; Minoru Itou; Tetsuharu Oriishi; Shoko Iwasaki; Hiroko Miura; Takuji Torimura
Journal:  Biomed Rep       Date:  2016-03-23

Review 2.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 3.  Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses.

Authors:  Pranav Periyalwar; Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2012-01-23       Impact factor: 6.126

Review 4.  Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.

Authors:  Siddheesh Rajpurohit; Balaji Musunuri; Pooja Basthi Mohan; Shiran Shetty
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

Review 5.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 6.  Clinical relevance of sarcopenia in patients with cirrhosis.

Authors:  Aldo J Montano-Loza
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

7.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

8.  Supplementation with Branched-Chain Amino Acids Induces Unexpected Deleterious Effects on Astrocyte Survival and Intracellular Metabolism with or without Hyperammonemia: A Preliminary In Vitro Study.

Authors:  Ting Wang; Kazuyuki Suzuki; Toshimi Chiba; Keisuke Kakisaka; Yasuhiro Takikawa
Journal:  Int J Hepatol       Date:  2021-09-10

Review 9.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

10.  Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis.

Authors:  Zhanyi Li; Yu Liu; Xiangyong Li; Yuankai Wu; Fangji Yang; Qiwan Mo; Yutian Chong
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.